- Malignant pleural mesothelioma (MPM) is an aggressive disease of the pleural lining with a dismal prognosis
- There is a resurgence of interest in lung-sparing extirpative surgery for malignant pleural mesothelioma with recent reports of better survival and fewer adverse consequences than with extrapleural pneumonectomy (EPP) – see NIH 2011
- There has been and continues to be a debate among mesothelioma doctors worldwide over which kind of surgery is best – extrapleural pneumonectomy and extended pleurectomy/decortication (P/D)
- The statistics from these reports show a positive side to the use of the lung-sparing procedure called extended P/D (extended pleurectomy/decortication (P/D))
- Another report from NIH 2013 shows the mortality rate with EPP is 6.9% while only 2.9% of studied patients die from extended P/D
Malignant pleural mesothelioma (MPM) is an aggressive disease of the pleural lining with a dismal prognosis. Mesothelioma can be contracted from asbestos exposure and many mesothelioma victims were in the armed forces, in particular, the Navy.
Asbestos fibers have been used in the manufacturing of a wide variety of industrial and household products in the United States and around the world. For more on mesothelioma and asbestos and on filing an asbestos lawsuit or mesothelioma lawsuit, please visit the links below:
- An Overview
- Asbestos Connection
- Exposure to Asbestos
- Signs and Symptoms
- Diagnosis/Staging and Treatment
- Go To Asbestos
- Asbestos & Mesothelioma News
At the Gooch Law Firm, we pride ourselves on providing our clients reliable representation for even the most challenging cases. If you have been diagnosed with mesothelioma and would like your case evaluated, contact our office at 1.844.329.5955.
WE ARE HERE TO HELP YOU PROTECT YOUR LEGAL RIGHTS